Upload Image (Max 20MB per Image)
Sygnis Pharma will join forces with X-Pol Biotech to secure sustainable business model. The company believes that the changes are essential after the termination of clinical development activities in December 2011. Sygnis' new business ...
Tags: Sygnis Pharma, X-Pol, DNA amplification technologies